Ventyx Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress

Go back to Ventyx Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress

Ventyx Biosciences, Inc. (VTYX) Tops Q2 EPS by 7c

August 15, 2022 4:28 PM EDT

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.39), $0.07 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

... More